Annual report pursuant to Section 13 and 15(d)

CONVERTIBLE LOANS (Narrative) (Details)

v3.10.0.1
CONVERTIBLE LOANS (Narrative) (Details)
$ / shares in Units, € in Millions, ₪ in Millions
1 Months Ended 12 Months Ended
Mar. 07, 2017
USD ($)
Nov. 02, 2016
USD ($)
Nov. 02, 2016
ILS (₪)
Apr. 30, 2018
shares
Mar. 31, 2018
USD ($)
$ / shares
Jan. 31, 2018
USD ($)
Mar. 20, 2017
shares
Feb. 27, 2017
Jan. 17, 2017
USD ($)
$ / shares
shares
Jan. 17, 2017
EUR (€)
shares
Nov. 30, 2018
USD ($)
$ / shares
shares
Nov. 30, 2017
USD ($)
$ / shares
shares
Debt Instrument, Convertible, Conversion Price | $ / shares         $ 0.52              
Class of Warrant or Right, Grants in Period, Net of Forfeitures | shares                     4,488,854 1,144,647
Class of Warrant or Right, Grants in Period, Exercise Price | $ / shares                     $ 6.24  
Repayments of Convertible Debt $ 494,000                   $ 177,000 $ 4,051,000
Debt Instrument, Interest Rate, Stated Percentage   2.00% 2.00%                  
Debt Conversion, Converted Instrument and Accrued Interest, Amount         $ 383,000              
Proceeds from issuance of convertible loans (net of transaction costs)   $ 280,000 ₪ 1               1,912,000 5,899,000
Debt Conversion, Converted Instrument, Amount                     $ 8,056,000  
Debt Conversion, Converted Instrument, Shares Issued | shares                     1,378,737  
Debt Conversion, Converted Instrument, Warrants or Options Issued | shares                     1,240,972  
Financial expenses                     $ 3,117,000 2,447,000
Repayments of Convertible Debt, shares issued | shares       107,985                
Nine Investments and Admiral Ventures Inc. [Member]                        
Class of Warrant or Right, Grants in Period, Exercise Price | $ / shares                     $ 6.24  
Repayments of Convertible Debt           $ 179,000         $ 1,875,000  
Units Issued During Period, Units | shares                     120,193  
Financial expenses                     $ 179,000 $ 983,000
Class of Warrant or Right, Grants in Period, Value                     $ 434,000  
Debt Instrument, Payment Terms               The Company agreed to pay to Admiral, on or before March 1, 2017, between $0.3 million and $1.5 million. Further, beginning April 2017, the Company agreed to make a monthly payment of $125 thousand on account of remaining unpaid balance, and also agreed to remit additional payments under the term of the agreement.        
MaSTherCell bondholder [Member]                        
Class of Warrant or Right, Grants in Period, Net of Forfeitures | shares                 8,569 8,569    
Class of Warrant or Right, Grants in Period, Exercise Price | $ / shares                 $ 6.24      
Repayments of Convertible Debt                 $ 1,700,000 € 1.5    
Adjustment of Warrants Granted for Services                 $ 20,000      
Debt Conversion, Converted Instrument, Shares Issued | shares             40,682          
Convertible Loans Outstanding 1 [Member]                        
Incremental Common Shares Attributable to Conversion of Debt Securities | shares                     178,570  
Debt Instrument, Convertible, Conversion Price | $ / shares                     $ 7  
Debt Instrument, Interest Rate, Stated Percentage                     2.00%  
Debt Instrument, Convertible, Beneficial Conversion Feature                     $ 114  
Convertible Loans Outstanding 1 [Member] | Hemogenyx-Cell [Member]                        
Pre-money valuation                     12,000,000  
Convertible Loans Outstanding 1 [Member] | Immugenyx, LLC [Member]                        
Pre-money valuation                     $ 8,000,000  
Convertible Loans converted 2 [Member]                        
Debt Instrument, Convertible, Conversion Price | $ / shares                     $ 6.24  
Class of Warrant or Right, Grants in Period, Net of Forfeitures | shares                     40,064  
Class of Warrant or Right, Grants in Period, Exercise Price | $ / shares                     $ 6.24  
Debt Instrument, Interest Rate, Stated Percentage                     6.00%  
Debt Instrument, Convertible, Beneficial Conversion Feature                     $ 106  
Debt Conversion, Converted Instrument, Amount                     $ 500,000  
Debt Conversion, Converted Instrument, Shares Issued | shares                     80,756  
Debt Conversion, Converted Instrument, Warrants or Options Issued | shares                     80,756  
Convertible Loans converted 4 [Member]                        
Debt Instrument, Convertible, Conversion Price | $ / shares                     $ 6.24  
Class of Warrant or Right, Grants in Period, Net of Forfeitures | shares                       145,509
Class of Warrant or Right, Grants in Period, Exercise Price | $ / shares                       $ 6.24
Debt Instrument, Interest Rate, Stated Percentage                     6.00%  
Debt Instrument, Convertible, Beneficial Conversion Feature                     $ 81  
Debt Conversion, Converted Instrument, Amount                     $ 798,000  
Debt Conversion, Converted Instrument, Shares Issued | shares                     134,372  
Debt Conversion, Converted Instrument, Warrants or Options Issued | shares                     34,269  
Convertible Loans converted 6 [Member]                        
Debt Instrument, Convertible, Conversion Price | $ / shares                     $ 4.8  
Debt Instrument, Convertible, Beneficial Conversion Feature                     $ 85  
Debt Conversion, Converted Instrument, Amount                     $ 100,000  
Debt Conversion, Converted Instrument, Shares Issued | shares                     37,662  
Debt Conversion, Converted Instrument, Warrants or Options Issued | shares                     0  
Convertible Loans converted 6 [Member] | Default Rate [Member]                        
Debt Instrument, Interest Rate, Stated Percentage                     24.00%